MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Evaluating Use of the DBS Patient Programmer

D. Whitney, J. Karl, G. Pal, D. Ocegueda-Ramirez, B. Ouyang, L. Verhagen Metman (Chicago, IL, USA)

Meeting: 2017 International Congress

Abstract Number: 328

Keywords: Deep brain stimulation (DBS), Interventions

Session Information

Date: Monday, June 5, 2017

Session Title: Surgical Therapy: Parkinson’s Disease

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To characterize use of the Medtronic® DBS patient programmer among patients with DBS for movement disorders.

Background: Patients who undergo deep brain stimulation receive a handheld device that can be used at home to check settings or adjust therapy, but this is an underutilized resource. There have not been any published studies evaluating patients’ impressions of this device, commonly or uncommonly used features, or barriers to more frequent or effective use.

Methods: A 21-item questionnaire was developed, focusing on patient demographics, patterns of device use including frequency and common features, comfort level with the device and technology in general, and education on use of the device. Questionnaires were distributed to interested DBS patients before or during routine clinic visits and collected by office staff.

Results: To date, 17 (85% of those approached) of a planned 50 patients have completed the questionnaire; continued data collection is ongoing. In this preliminary group, patients tended to be male (64.7%), younger than 60 years old (58.8%), and have DBS for Parkinson’s disease (76.5%). Patients most frequently use their patient programmer once per month or less (76.5%), while 17.7% never do. There was no difference in frequency of use among younger versus older patients. Patients most frequently use the device to check DBS battery life (58.8%), or change therapy settings using groups (41.2%) or individual stimulation parameters (41.2%). Patients generally felt ‘somewhat’ or ‘very’ comfortable with using the device (70.6% for the basic features and 75% for the more advanced features). Some thought they would benefit from refreshers on common features (35.3%) or a quick reference guide (23.5%), but many (35.3%) did not want or need further education. Patients were split on whether they would use a smart phone or tablet application more than the standalone device, with 47.1% ‘somewhat’ or ‘much’ more likely to use an application while 41.2% were neither more or less likely; there was no correlation with patients’ overall comfort level with these technologies.

Conclusions: In our preliminary data group, patients generally reported not using their DBS patient programmer much despite relative comfort with the device. With a larger sample size we hope to identify trends that could lead to better patient education and ultimately more frequent and effective use of this device.

To cite this abstract in AMA style:

D. Whitney, J. Karl, G. Pal, D. Ocegueda-Ramirez, B. Ouyang, L. Verhagen Metman. Evaluating Use of the DBS Patient Programmer [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/evaluating-use-of-the-dbs-patient-programmer/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/evaluating-use-of-the-dbs-patient-programmer/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley